Spruce Biosciences, Inc (SPRB) Price Prediction & ForecastSPRBSpruce Biosciences, Inc

Alphio's SPRB stock price prediction model matches the current Spruce Biosciences, Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $42.28 (-1.00%). The 1-week path is $42.12 (-1.38%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Spruce Biosciences Inc (SPRB) is a good buy right now, trading at $44.55, significantly below its 52-week high of $129. The stock has a forward P/E of 0, indicating potential for future earnings growth as it develops its lead asset, TA-ERT, which has received favorable designations from the FDA. Analysts project a price target of $149, suggesting a potential upside of over 335% from the current price. However, the company reported a disappointing Q1 EPS of -$8.94, which missed expectations and reflects ongoing profitability challenges, presenting a risk to investors.

Spruce Biosciences, Inc (SPRB) last closed at $42.7099991, losing -8.37%. These facts feed the 1-day and 1-week SPRB price prediction above.